Tainted Medication Fears Spur Defense Department to Seek Outside Testing August 10, 2023 By Anna Edney and Riley Griffin The US Department of Defense entered an agreement with Valisure, an independent lab that’s spotted dangerous chemicals in a variety...
Teva Agrees to Pay $126M to US Hospitals Over Opioids August 4, 2023 By Brendan Pierson Teva Pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals over 18 years to settle...
EU Widens Probe of Suicide Risks Linked to Weight-Loss Drugs July 13, 2023 By Suzi Ring, Nacha Cattan and Madison Muller The European Union’s drug regulator expanded its investigation into a possible risk of suicidal thoughts associated with a new class...
Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute May 16, 2023 By Blake Brittain The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc’s challenge to a $235 million award to...
Worker’s Body Recovered at Site of Explosion at Massachusetts Plant With Fire History May 5, 2023 The body of a worker who died in an explosion at a Newburyport, Massachusetts chemical plant has been recovered and...
U.S. Sues Rite Aid for Missing Opioid Red Flags March 14, 2023 By Jonathan Stempel The U.S. government on Monday sued Rite Aid Corp., accusing the pharmacy chain of missing “red flags” as it illegally...
U.S. Opioid Crackdown Hits Some Patients’ Access to Psychiatric Drugs December 12, 2022 By Ahmed Aboulenein A crackdown by U.S. drug wholesalers in response to the opioid crisis is preventing some pharmacists from dispensing a combination...
Teva, AbbVie Finalize $6.6B Opioid Settlements November 23, 2022 By Brendan Pierson Teva Pharmaceutical Industries Ltd. and AbbVie Inc. have finalized the terms of settlements worth more than $6.6 billion to resolve...
Britain’s Haleon Rejects Potential Zantac Liabilities in U.S. September 21, 2022 By Natalie Grover Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac,...
FDA Chief Says Opioid Review Still in the Works September 1, 2022 By Matthew Perrone A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway...